• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Ngs Sample Preparation Market

    ID: MRFR/HC/32095-HCR
    100 Pages
    Rahul Gotadki
    October 2025

    NGS Sample Preparation Market Research Report By Application (Clinical Diagnostics, Drug Discovery, Personalized Medicine, Agricultural Biotechnology), By Product Type (Library Preparation Kits, Purification Kits, Consumables, Instruments), By Workflow (Quality Control, Sample Preparation, Library Preparation, Data Analysis), By End User (Pharmaceutical Companies, Research Institutions, Clinical Laboratories, Biotechnology Companies) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Ngs Sample Preparation Market Infographic

    Ngs Sample Preparation Market Summary

    As per MRFR analysis, the NGS Sample Preparation Market Size was estimated at 2.735 USD Billion in 2024. The NGS Sample Preparation industry is projected to grow from 3.041 USD Billion in 2025 to 8.777 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 11.18 during the forecast period 2025 - 2035.

    Key Market Trends & Highlights

    <p>The NGS Sample Preparation Market is poised for substantial growth driven by technological advancements and increasing demand for personalized medicine.</p>

    • Automation in sample preparation is becoming increasingly prevalent, enhancing efficiency and accuracy in workflows.
    • Customization of sample preparation solutions is gaining traction, catering to diverse research needs across various applications.
    • Collaborative research initiatives are fostering innovation and accelerating the development of next-generation sequencing technologies.
    • Technological advancements in NGS and the rising demand for personalized medicine are key drivers propelling market growth, particularly in North America and Asia-Pacific, with clinical diagnostics and library preparation kits leading the segments.

    Market Size & Forecast

    2024 Market Size 2.735 (USD Billion)
    2035 Market Size 8.777 (USD Billion)
    CAGR (2025 - 2035) 11.18%

    Major Players

    Illumina (US), Thermo Fisher Scientific (US), Qiagen (DE), Roche (CH), Agilent Technologies (US), PerkinElmer (US), Bio-Rad Laboratories (US), New England Biolabs (US), Takara Bio (JP)

    Ngs Sample Preparation Market Trends

    The NGS Sample Preparation Market is currently experiencing a transformative phase, driven by advancements in technology and increasing demand for genomic research. The rise of personalized medicine and the growing emphasis on precision diagnostics are propelling the need for efficient and reliable sample preparation methods. As researchers and healthcare professionals seek to harness the power of next-generation sequencing, the market is witnessing a surge in innovative solutions that streamline workflows and enhance data quality. Furthermore, the integration of automation and robotics into sample preparation processes appears to be a key trend, potentially reducing human error and increasing throughput. In addition, the NGS Sample Preparation Market is likely to benefit from collaborations between academic institutions and biotechnology companies. These partnerships may foster the development of novel reagents and kits that cater to specific research needs. Moreover, the increasing accessibility of sequencing technologies is expected to broaden the user base, encompassing not only large research facilities but also smaller laboratories and clinical settings. This democratization of genomic technologies could lead to a more widespread adoption of NGS methodologies, ultimately shaping the future landscape of the market.

    Automation in Sample Preparation

    The integration of automation technologies into the NGS Sample Preparation Market is becoming increasingly prevalent. Automated systems are designed to enhance efficiency, minimize human error, and streamline workflows. This trend suggests that laboratories are likely to adopt these solutions to cope with the growing volume of samples and the need for rapid turnaround times.

    Focus on Customization

    There is a noticeable shift towards customized sample preparation solutions tailored to specific research applications. This trend indicates that manufacturers are responding to the diverse needs of researchers by offering specialized kits and reagents. Such customization may enhance the accuracy and reliability of sequencing results, thereby supporting a wide range of genomic studies.

    Collaborative Research Initiatives

    Collaborations between academic institutions and industry players are emerging as a significant trend within the NGS Sample Preparation Market. These partnerships appear to facilitate the exchange of knowledge and resources, leading to the development of innovative products. Such initiatives may accelerate advancements in sample preparation techniques, ultimately benefiting the broader scientific community.

    The increasing demand for personalized medicine and advancements in genomic technologies are driving the evolution of the NGS sample preparation market, highlighting its critical role in enhancing diagnostic capabilities and therapeutic strategies.

    National Institutes of Health (NIH)

    Ngs Sample Preparation Market Drivers

    Technological Advancements in NGS

    The NGS Sample Preparation Market is experiencing a surge in technological advancements that enhance the efficiency and accuracy of sample preparation processes. Innovations such as automated liquid handling systems and advanced library preparation kits are streamlining workflows, thereby reducing the time and labor involved in sample preparation. According to recent data, the market for automated sample preparation systems is projected to grow at a compound annual growth rate of approximately 10% over the next five years. These advancements not only improve throughput but also minimize the risk of contamination, which is critical for obtaining reliable sequencing results. As laboratories increasingly adopt these technologies, the NGS Sample Preparation Market is likely to witness significant growth, driven by the demand for high-quality genomic data.

    Increased Funding for Genomic Research

    The NGS Sample Preparation Market is benefiting from increased funding for genomic research initiatives. Governments and private organizations are investing heavily in genomics to advance understanding of diseases and develop new therapies. For instance, funding for genomics research has seen a substantial rise, with estimates suggesting an increase of over 15% in research grants allocated to genomic studies in recent years. This influx of capital is likely to enhance the capabilities of laboratories, allowing for the acquisition of advanced sample preparation technologies. As research institutions expand their genomic capabilities, the demand for high-quality NGS sample preparation solutions is expected to grow, further propelling the NGS Sample Preparation Market.

    Rising Demand for Personalized Medicine

    The NGS Sample Preparation Market is significantly influenced by the rising demand for personalized medicine. As healthcare shifts towards more individualized treatment approaches, the need for precise genomic data becomes paramount. NGS technologies enable the analysis of genetic variations that can inform tailored therapies, thus driving the demand for efficient sample preparation methods. Market data indicates that the personalized medicine sector is expected to reach a valuation of over 2 trillion by 2026, which will likely propel the NGS Sample Preparation Market forward. This trend underscores the necessity for robust sample preparation solutions that can handle diverse sample types and complexities, ensuring that clinicians have access to accurate genomic information for patient care.

    Growing Applications in Clinical Diagnostics

    The NGS Sample Preparation Market is witnessing growth due to the expanding applications of NGS in clinical diagnostics. As healthcare providers increasingly adopt NGS for disease detection and monitoring, the need for efficient sample preparation methods becomes critical. NGS technologies are being utilized for a variety of clinical applications, including oncology, infectious diseases, and genetic disorders. Market analysis indicates that the clinical diagnostics segment of the NGS market is projected to account for a significant share, potentially exceeding 40% by 2025. This trend highlights the necessity for reliable and scalable sample preparation solutions that can support the increasing volume of clinical samples, thereby driving growth in the NGS Sample Preparation Market.

    Emergence of Next-Generation Sequencing Platforms

    The NGS Sample Preparation Market is being shaped by the emergence of next-generation sequencing platforms that require specialized sample preparation techniques. As new sequencing technologies are developed, they often necessitate unique sample preparation workflows to optimize performance and data quality. The introduction of platforms with enhanced throughput and accuracy is likely to create a demand for innovative sample preparation solutions tailored to these technologies. Market projections suggest that the NGS platform segment will experience a growth rate of around 12% annually, which will, in turn, stimulate the NGS Sample Preparation Market. This dynamic interplay between sequencing technology advancements and sample preparation needs underscores the importance of adaptability in the market.

    Market Segment Insights

    By By Application: Clinical Diagnostics (Largest) vs. Drug Discovery (Fastest-Growing)

    In the NGS Sample Preparation Market, the 'Application' segment is primarily dominated by Clinical Diagnostics, which holds a significant market share due to its widespread adoption in healthcare settings. Following closely is Drug Discovery, which is gaining traction as pharmaceutical companies increasingly leverage NGS technologies to streamline their research and development processes. Personalized Medicine and Agricultural Biotechnology also contribute to the segment, albeit to a lesser extent, reflecting evolving industry trends toward tailored healthcare solutions and innovative agricultural practices.

    Clinical Diagnostics (Dominant) vs. Drug Discovery (Emerging)

    Clinical Diagnostics has emerged as the dominant application within the NGS Sample Preparation Market, driven by the growing need for precise and accurate diagnostic tools in healthcare. This segment benefits from established infrastructure, consistent demand, and a regulatory framework that supports its use. On the other hand, Drug Discovery is recognized as an emerging application, characterized by its rapid growth spurred by advancements in genetic research and the need for more targeted therapies. Investment in biotechnology and growing collaborations between research institutions and pharmaceutical companies are key drivers fostering this trend. As both applications evolve, they symbolize the dual pathways of innovation and implementation within the NGS landscape.

    By By Product Type: Library Preparation Kits (Largest) vs. Instruments (Fastest-Growing)

    In the NGS Sample Preparation Market, the product type segment comprises Library Preparation Kits, Purification Kits, Consumables, and Instruments. Among these, Library Preparation Kits hold the largest market share, attributed to their essential role in preparing genomic libraries for sequencing. Instruments, while currently smaller in share, are recognized for their rapid growth as advancements in technology drive demand for more efficient and automated solutions in sample preparation.

    Library Preparation Kits (Dominant) vs. Instruments (Emerging)

    Library Preparation Kits are the dominant product in the NGS Sample Preparation Market due to their critical role in the sequencing pipeline. These kits offer comprehensive solutions, ensuring high-quality library preparation, which is fundamental for accurate sequencing results. On the other hand, Instruments represent an emerging sector with significant growth potential. They are increasingly being adopted by research and clinical laboratories for their ability to automate and streamline workflows, thus reducing manual errors and turnaround times. The growth in this segment is fueled by innovations such as integrated solutions that enhance the speed and efficiency of sample preparation.

    By By Workflow: Library Preparation (Largest) vs. Quality Control (Fastest-Growing)

    In the NGS Sample Preparation Market, Library Preparation currently holds the largest market share among the workflow segments, primarily due to its critical role in converting genomic DNA or RNA into a format suitable for sequencing. As researchers increasingly pursue high-throughput sequencing applications, the demand for effective library preparation methods continues to rise. Quality Control, on the other hand, is experiencing rapid growth as rigorous standards in genomic analytics necessitate reliable quality checks during sample preparation processes.

    Library Preparation (Dominant) vs. Quality Control (Emerging)

    Library Preparation has solidified its position as the dominant workflow segment in the NGS Sample Preparation Market, driven by advancements in reagent technology and automation solutions that enhance throughput and efficiency. This segment is characterized by a range of techniques designed to optimize the conversion of samples into sequencing-ready libraries, ensuring high fidelity and comprehensiveness. Conversely, Quality Control is an emerging segment that is rapidly gaining importance due to increasing regulatory demands and a heightened emphasis on reproducibility. This segment focuses on the methodological assessment of sample quality, incorporating innovative technologies that facilitate real-time monitoring and analysis. Together, these segments drive the market towards refined and reliable genomic data generation.

    By By End User: Pharmaceutical Companies (Largest) vs. Research Institutions (Fastest-Growing)

    The NGS Sample Preparation Market exhibits a diverse distribution among key end users. Pharmaceutical Companies hold the largest market share, driven by their extensive investment in next-generation sequencing technologies for drug development and personalized medicine. In contrast, Research Institutions are rapidly expanding their footprint in this market, leveraging advanced sequencing techniques for genomic research and innovations in various scientific fields. This shift highlights the dynamic interplay between established industry players and emerging research-focused entities in the NGS landscape. Growth trends indicate that while Pharmaceutical Companies continue to dominate the market due to their ability to allocate substantial resources towards technological advancements and product development, Research Institutions are emerging as significant players. Their demand for innovative NGS solutions is propelled by the increasing need for genomic data in personalized healthcare initiatives and academic research. The collaboration between these two segments underscores a synergistic relationship that fuels the overall growth of the NGS sample preparation market.

    Pharmaceutical Companies (Dominant) vs. Biotechnology Companies (Emerging)

    Pharmaceutical Companies are currently the dominant force in the NGS Sample Preparation Market, capitalizing on their well-established networks, substantial funding, and strong emphasis on drug discovery and development processes. Their robust demand for NGS solutions is driven by the need for precision medicine and advanced therapeutic options. In comparison, Biotechnology Companies represent an emerging segment, harnessing novel biotechnological methodologies to enhance genomic analyses and drive innovation in product offerings. As they adopt NGS technologies, these companies are revolutionizing research and development activities, creating a competitive yet synergistic ecosystem within the market. Their agility and focus on innovative applications position them to capture market share, complementing the foundational strength of their pharmaceutical counterparts.

    Get more detailed insights about Ngs Sample Preparation Market

    Regional Insights

    The NGS Sample Preparation Market revenue is showcasing substantial growth across various regions, positioning itself for further expansion over the coming years. In 2023, North America led with a market valuation of 0.88 USD billion, reflecting its majority holding in the market due to advanced research facilities and high investments in biotechnology.

    Following closely, Europe held a significant position with a valuation of 0.62 USD billion, driven by a robust healthcare infrastructure and increasing genomics applications. APAC, with a market valuation of 0.42 USD billion, illustrated growing interest and investments in genomics, enhancing its importance in the global landscape.

    Meanwhile, South America and MEA, valued at 0.14 USD billion and 0.16 USD billion respectively in 2023, are gradually emerging as important regions, incentivized by evolving healthcare needs and technology adoption.

    Despite their smaller contributions to the overall market, their growth potential presents opportunities for market players looking to expand their footprint in these regions. Each of these areas contributes uniquely to the NGS Sample Preparation Market dynamics, as seen through their varied valuations and growth trajectories.

    NGS Sample Preparation Market Regional Insights

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Key Players and Competitive Insights

    The NGS Sample Preparation Market is characterized by rapid evolution and innovation, driven by the increasing demand for next-generation sequencing techniques across various applications in genomics, drug discovery, and molecular diagnostics.

    This market showcases a blend of established players and emerging companies, each working to enhance sample preparation processes, minimize errors, and improve the efficiency of sequencing workflows. In this vibrant landscape, the competitive dynamics are influenced by technological advancements, strategic collaborations, and the integration of automation in sample preparation procedures.

    Key players are engaged in addressing market demands by providing tailored solutions while also expanding their product portfolios to cater to the diverse needs of researchers and laboratories worldwide.

    Oxford Nanopore Technologies holds a strong position within the NGS Sample Preparation Market, bolstered by its novel approaches to sequencing technology that encompass portability and real-time analysis. The company has made significant advancements in making sequencing more accessible and user-friendly, differentiating itself through products that offer flexibility and adaptability in sample preparation.

    This capability to operate within various environments, from research institutions to field studies, gives Oxford Nanopore Technologies a competitive edge. Furthermore, their emphasis on rapid turnaround times and the capacity to handle complex samples enhances their appeal in the academic and clinical sectors.

    The commitment to innovation and customer engagement solidifies their presence in this competitive market, making them a preferred choice among researchers needing efficient and reliable NGS sample preparation solutions.

    BioRad Laboratories is another significant player in the NGS Sample Preparation Market, recognized for its comprehensive portfolio of high-quality products designed to enhance the sequencing process. Their strengths lie in the development of innovative tools and reagents that streamline sample preparation workflows, improving overall lab efficiency.

    BioRad Laboratories benefits from a robust distribution network and a strong brand reputation built on reliability and performance in laboratory products. The company's integration of automation solutions and digital tools into sample preparation procedures positions it effectively to meet the growing demands for high-throughput sequencing capabilities.

    Moreover, BioRad Laboratories focuses on continuous improvement and customer feedback, enabling them to adapt their offerings in alignment with the evolving needs of the market, ultimately enhancing their competitive stance in the realm of NGS sample preparation.

    Key Companies in the Ngs Sample Preparation Market market include

    Industry Developments

    • Q1 2024: WHO publishes new recommendations on the use of targeted next-generation sequencing (NGS) tests for the diagnosis of drug-resistant tuberculosis The World Health Organization released new guidelines recommending the use of targeted NGS tests for rapid detection of drug resistance in tuberculosis, marking a significant regulatory development for NGS sample preparation technologies in clinical diagnostics.

    Future Outlook

    Ngs Sample Preparation Market Future Outlook

    The NGS Sample Preparation Market is projected to grow at 11.18% CAGR from 2024 to 2034, driven by advancements in genomic technologies, increasing demand for personalized medicine, and rising investments in research and development.

    New opportunities lie in:

    • Develop automated sample preparation systems to enhance throughput and reduce human error. Invest in partnerships with biotech firms to co-develop innovative NGS workflows. Expand product offerings to include eco-friendly reagents and consumables for sustainable practices.

    By 2035, the NGS Sample Preparation Market is expected to achieve substantial growth, reflecting its critical role in genomic research.

    Market Segmentation

    NGS Sample Preparation Market End User Outlook

    • Pharmaceutical Companies
    • Research Institutions
    • Clinical Laboratories
    • Biotechnology Companies

    NGS Sample Preparation Market Regional Outlook

    • North America
    • Europe
    • South America
    • Asia Pacific
    • Middle East and Africa

    NGS Sample Preparation Market Workflow Outlook

    • Quality Control
    • Sample Preparation
    • Library Preparation
    • Data Analysis

    NGS Sample Preparation Market Application Outlook

    • Clinical Diagnostics
    • Drug Discovery
    • Personalized Medicine
    • Agricultural Biotechnology

    NGS Sample Preparation Market Product Type Outlook

    • Library Preparation Kits
    • Purification Kits
    • Consumables
    • Instruments

    Report Scope

    Report Attribute/MetricDetails
    Market Size 2024   2.73 (USD Billion)
    Market Size 2025   3.04 (USD Billion)
    Market Size 20358.78 (USD Billion)
    Compound Annual Growth Rate (CAGR)11.18% (2025 - 2035)
    Report CoverageRevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year2024
    Market Forecast Period2025 - 2035
    Historical Data2020 - 2024
    Market Forecast UnitsUSD billion
    Key Companies ProfiledOxford Nanopore Technologies, BioRad Laboratories, New England Biolabs, Illumina, Qiagen, Promega, Macrogen, Thermo Fisher Scientific, Agilent Technologies, Takara Bio, Roche, PerkinElmer, Genomatix, Becton Dickinson, Danaher
    Segments CoveredApplication, Product Type, Workflow, End User, Regional
    Key Market OpportunitiesGrowing demand for personalized medicine, Advancements in genomic research technologies, Increasing adoption of NGS in diagnostics, Rising investment in precision health initiatives, Expanding applications in oncology research
    Key Market DynamicsIncreasing demand for personalized medicine, Advancements in sequencing technologies, Rising applications in genomics research, Growth of biobanks and biorepositories, Increasing funding for genomics initiatives
    Countries CoveredNorth America, Europe, APAC, South America, MEA

    Leave a Comment

    FAQs

    What is the projected growth of the NGS sample preparation market?

    The NGS sample preparation market is the expected increase in total market value of 8.78 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

    What is the size of the NGS sample preparation market?

    NGS sample preparation market size was valued at approximately 2.73 billion USD in 2024. This figure will reach 8.78 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

    What is the CAGR of the NGS sample preparation market?

    NGS sample preparation market is expected to grow at a CAGR of 11.18% between 2025 and 2035.

    How much will the NGS sample preparation market be worth by 2035?

    NGS sample preparation market is expected to be worth of 8.78 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

    How will the NGS sample preparation market perform over the next 10 years?

    Over the next 10 years the NGS sample preparation market is expected to shift from usd billion 2.73 to 8.78 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

    Which region is expected to dominate the NGS sample preparation market by 2035?

    North America is projected to dominate the NGS sample preparation market with a value of 2.22 billion USD by 2035.

    How is the Clinical Diagnostics segment valued in 2024, and what is its projection for 2035?

    The Clinical Diagnostics segment is valued at 0.92 billion USD in 2024 and is projected to reach 2.35 billion USD by 2035.

    Which key players are involved in the NGS Sample Preparation Market?

    Major players in the market include Oxford Nanopore Technologies, BioRad Laboratories, and Illumina, among others.

    What is the expected value of the Agricultural Biotechnology segment by 2035?

    The Agricultural Biotechnology segment is expected to reach 0.87 billion USD by 2035.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials

    Compare Licence

    ×
    Features License Type
    Single User Multiuser License Enterprise User
    Price $4,950 $5,950 $7,250
    Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
    Free Customization
    Direct Access to Analyst
    Deliverable Format
    Platform Access
    Discount on Next Purchase 10% 15% 15%
    Printable Versions